Drupal.behaviors.print = function(context) {window.print();window.close();}>
BioMolecular Therapeutics Inks Deal with Samyang, Aims for Korean IND in '13
February 09, 2012
BioMolecular Therapeutics Inks Deal with Samyang, Aims for Korean IND in '13
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Following Private Placement, RXi Has Funds to Last into 2015
April 4, 2013 / Gene Silencing News
RXi Releases Blinded Phase I Data Hinting at Efficacy of Anti-Scarring Drug, On Track for Phase II
February 21, 2013 / Gene Silencing News
RXi Begins Second Phase I Trial of Anti-Scarring Drug
December 6, 2012 / Gene Silencing News
RXi Releases Positive Safety Data on Scarring Drug, Posts Higher Q3 Loss on Dividend
November 15, 2012 / Gene Silencing News
RXi Completes Enrollment in Phase I Anti-Scarring Drug Trial
September 27, 2012 / Gene Silencing News